Skip navigation

News

Business Weeklywww.businessweekly.co.uk


Heptares scientists solve structure of complement C5a receptor, an important drug target for inflammatory and neurodegenerative

Publication in Nature highlights opportunities to target C5a receptor with selective small molecules via novel mechanism of action More »
04 January 2018

ARECOR AND JDRF ANNOUNCE SUCCESSFUL PRE-CLINICAL DEVELOPMENT

ARECOR AND JDRF ANNOUNCE SUCCESSFUL PRE-CLINICAL DEVELOPMENT OF STABLE RAPID-ACTING, ULTRA-CONCENTRATED INSULIN FOR THE SIGNIFICANTLY ENHANCED TREATMENT OF TYPE 1 DIABETES “Arecor’s proprietary insulin product to progress into human clinical trials in 2018” More »
04 January 2018

Inivata to present at the Biotech ShowcaseTM in San Francisco

Company will also participate in “Generation Genome and Industrial Strategy: Leveraging UK Leadership in Genomics” Panel More »
04 January 2018

Call for 2018 CRACK IT Challenges

Open Call for 2018 CRACK IT Challenges More »
04 January 2018

Examination of Non-sterile Products: Application Note Published in European Pharmaceutical Review

More »
04 January 2018

Horizon Discovery Enters Into Agreement with Roche Diagnostics to Support the Development of Immunohistochemistry Assays

Horizon Discovery today announces that it has entered into an agreement with Roche Diagnostics to assist in the development of immunohistochemistry assays More »
18 December 2017

Concept Life Sciences Achieves Record Profits and Strengthens Senior Team

Concept Life Sciences (Concept), the integrated drug discovery, development and analytical services company, today announced a successful financial year, ending 2017 with revenues in excess of $65m/£49m. The Company also welcomes Dr Andrew Scott as Head of Bioassay Development and Screening, and Magalie Ferbach as Business Development Director for Southern and Central Europe. More »
18 December 2017

Global Healthcare Investor Perception Report to be launched at Biotech and Money / Medtech and Money World Congress.

Trends and truth in life science investment’ is the latest annual report, published by Biotech and Money, to offer unique and actionable insight into investor attitudes, biases and preferences in healthcare opportunities in Europe. More »
14 December 2017

Proximagen Enhances Medicinal Chemists’ Toolkit with Flare for Structure-Based Design

Cresset, innovative provider of software and contract research services for small molecule discovery and design, is pleased to announce that Proximagen, a drug discovery and development company, has licensed Flare. More »
12 December 2017

STORM Therapeutics Announces Appointments to Scientific Advisory Board

STORM Therapeutics, the leading drug discovery company focused on the discovery of small molecule therapies modulating RNA epigenetics, today announced the appointment of both Professor Mark Dawson and Dr Paul Leeson to the Scientific Advisory Board. More »
11 December 2017

<< Previous   Page 2 of 34   Next >>